
GSK3987
CAS No. 264206-85-1
GSK3987 ( —— )
产品货号. M27880 CAS No. 264206-85-1
GSK3987 是一种 LXR 配体。 GSK3987 将类固醇受体辅激活因子 1 募集至人 LXRalpha 和 LXRbeta,EC50 为 40 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2066 | 有现货 |
![]() ![]() |
10MG | ¥3345 | 有现货 |
![]() ![]() |
25MG | ¥5605 | 有现货 |
![]() ![]() |
50MG | ¥7979 | 有现货 |
![]() ![]() |
100MG | ¥10773 | 有现货 |
![]() ![]() |
500MG | ¥21546 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称GSK3987
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GSK3987 是一种 LXR 配体。 GSK3987 将类固醇受体辅激活因子 1 募集至人 LXRalpha 和 LXRbeta,EC50 为 40 nM。
-
产品描述GSK3987 is an LXR ligand. GSK3987 recruits the steroid receptor coactivator-1 to human LXRalpha and LXRbeta with EC50s of 40 nM.(In Vitro):In primary human macrophages, GSK3987 (30, 100, 300, 1000 nM) increased the expression of ABCA1 and induces cellular cholesterol efflux to apoA1 particles in a dose-dependent manner. In human hepatoma (HepG2) cells, GSK3987 (6-1500 nM) increases the expression of SREBP-1c and induces triglyceride accumulation in a dose-dependent manner. GSK3987 showed activity with EC50s of 0.08 μM, 50 nM, 40 nM for ABCA1, LXRα-SRC1, LXRβ-SRC1, respectively.
-
体外实验RT-PCR Cell Line:HepG2 cells Concentration:6-1500 nM Incubation Time:Result:Increased the expression of SREBP-1c and induced triglyceride accumulation in human hepatoma (HepG2) cells in a dose-dependent manner.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体EP4
-
研究领域——
-
适应症——
化学信息
-
CAS Number264206-85-1
-
分子量384.435
-
分子式C24H20N2O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (260.13 mM)
-
SMILESCOc1ccc(NC2=C(C(=O)N(Cc3ccccc3)C2=O)c2ccccc2)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Yang JJ,?et al. Discovery and Characterization of 1H-1,2,3-Triazole Derivatives as Novel Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy. J Med Chem.?2020 Jan 23;63(2):569-590.
产品手册




关联产品
-
Calcitonin, eel
Calcitonin, eel is the thyroid hormone peptide that contributes to the regulation of calcium homeostasis, widely used in the research of postmenopausal osteoporosis.
-
N-Carbethoxy-4-piper...
氨基嘧啶衍生物、其制备方法、含有它们的组合物及其作为化合物的用途。
-
Cadralazine
Cadralazine 是一种外周小动脉血管扩张剂,可用于作为抗高血压药物的研究。